FDA device listing

DASH® Negative Control,DASH® Rapid PCR Instrument,DASH® SARS-CoV-2 & Flu A B Positive Control,DASH® SARS-CoV-2 & Flu A/B…

FDA device listing 1456097506 · Nuclein, LLC

Key facts

Proprietary names DASH® Negative Control,DASH® Rapid PCR Instrument,DASH® SARS-CoV-2 & Flu A B Positive Control,DASH® SARS-CoV-2 & Flu A/B Test
Owner/operator Nuclein, LLC
Owner/operator number 10092415
Premarket submissions K241652
Product codes NSU, QOF
Device names NSU - Instrumentation For Clinical Multiplex Test Systems, QOF - Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device class Class II
Classification regulations (21 CFR) 862.2570, 866.3981
Review panels Clinical Chemistry, Microbiology
Registered establishments Nuclein, LLC
Establishment registrations 3014515702, 3035381641
FEI numbers 3014515702, 3035381641
Establishment operations Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings